ASMI congratulates Minister Ley on re-appointment
19 July 2016
The Australian Self Medication Industry (ASMI) today congratulated on Sussan Ley on her reappointment as Federal Health Minister.
ASMI Chief Executive Officer, Deon Schoombie, said: “We look forward to continuing the constructive relationship we’ve had with Minister Ley and her office, and working on addressing our industry’s key issues.”
ASMI is keen to progress regulatory reforms on consumer communication of Pharmacist-Only (Schedule 3) Medicines, an overhaul of the scheduling framework and provisions for market exclusivity/data protection over-the counter and complementary medicines to incentivise innovation.
“These regulatory reforms would stimulate investment and innovation by the non-prescription medicines sector, and take pressure off the already stretched health budget. We are eager to maintain momentum on these reforms now the election is behind us and the ministry is confirmed” he added
World Self Medication Industry General Assembly 2017: The Economics of Self Care
18 July 2016
In October 2017, the Australian Self Medication Industry (ASMI) and the New Zealand Self Medication Industry (NZSMI) are co-hosting the World Self Medication Industry (WSMI) General Assembly.
This is the biggest event on the global non-prescription medicines industry’s calendar and the theme of the conference is the economic value of self care and non-prescription medicines.
The event will be held at Sydney’s stunning new International Convention Centre at Darling Harbour.
ASMI Chief Executive Officer, Deon Schoombie, said:
“ASMI is very honoured to be hosting WSMI’s prestigious conference, which will attract leading regulators, academics and representatives of the consumer healthcare products industry from around the world.”
“A formidable line up of local and international speakers will discuss important elements of the economics of self care such as access to medicines, affordability and consumer empowerment, and how these can contribute towards better public health outcomes and sustainable healthcare, ” said NZSMI Executive Director, Scott Milne.
“The conference will showcase evidence-based models supporting enhanced self care, and the role of non-prescription medicines in individual and public health.”
Deon Schoombie added:
“On the second day of the conference Australia’s Therapeutic Goods Administration (TGA) will host the Regulator’s Forum, where international and local regulators will share their views on the unique challenges and opportunities in relation to the regulation of non-prescription medicines.
“We are greatly looking forward to welcoming international visitors and local delegates to this conference, which will be an exceptional opportunity to tap into the latest intelligence on the global consumer healthcare products industry and network with the world’s leaders in this dynamic sector.
“We ask all our stakeholders to quarantine the date in their organisation’s calendar to avoid the event clashing with other events,” he stated.
To register your interest in receiving more information on this event please click HERE.
Attractive foundation sponsorship and partnership opportunities are available to promote your brand to the global leaders in the consumer healthcare products sector. For more information: david@asmi.com.au